Partner Headlines - BIIB

  1. Top Funds Buying Rackspace, Allergan ogen Idec, Apple

    IBD
  2. Big Cap 20 Reflecting Market Leadership

    IBD
  3. How To Invest: Avoid Bases Of Low-Priced Stocks

    IBD
  4. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD
  5. The Catalysts Biogen Idec Investors Should Watch

    Benzinga
  6. United Therapeutics Blood Pressure Drug Spurs Q4 Beat

    IBD
  7. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD
  8. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD
  9. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  10. February Pick Of Biotech Stocks

    GuruFocus
  11. Stanley Druckenmiller's Recent Trades

    GuruFocus
  12. 8 Strong Recommendations for 2015

    GuruFocus
  13. Stocks End Mixed: Molina Healthcare Rises Again

    IBD
  14. Stocks Open Mixed, Techs Climb; Rite Aid, Akamai, AmTrust Jump

    IBD
  15. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD
  16. No Deceleration Here: 14 Stocks With Accelerating Profits

    IBD
  17. Nuveen's Bob Doll Runs Several Top Funds

    IBD
  18. Top Performing Funds Favor Leisure, Medical, REITs

    IBD
  19. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga
  20. Super Bowl Stocks: Seattle's Best Vs. Boston Strong

    IBD
  21. Many Leading Stocks Stumble But Biogen, Harman Soar

    IBD
  22. Stocks Slide Into Closing Bell; Day's Winners: Amazon, Biogen

    IBD
  23. Indexes Mired In Red; Amazon, Biogen, Visa Buck Trend

    IBD
  24. Stocks Extend Losses; Biogen Idec Gains

    IBD
  25. Stocks Open Down In Weak Trade; Biogen, Visa Soar On Q4 Results

    IBD
  26. Stocks Hitting 52-Week Highs

    Benzinga
  27. Morning Market Gainers

    Benzinga
  28. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  29. Biotechs' Earnings Buoy Street Despite FX Headwinds

    IBD
  30. Biogen, Alexion Soar On EPS

    IBD
  31. Making Money With Charles Payne: 01/29/15

    FoxBusiness
  32. Biogen Idec Q4 Net Nearly Doubles; Beats Views

    Benzinga
  33. Alexion Beats Q4 Estimates, Appoints New CEO

    IBD
  34. Credit Suisse Previews Biogen, Says 'Consensus Tecfidera Downgrades ...

    Benzinga
  35. Earnings Scheduled For January 29, 2015

    Benzinga
  36. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD
  37. Stocks Fade Badly; EA Hangs Tough

    IBD
  38. Earnings Scheduled For January 28, 2015

    Benzinga
  39. Must Watch Stocks for January 28, 2015

    Benzinga
  40. Big Cap Stocks Mylan, American Tower Near Buy Points

    IBD
  41. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga
  42. Apple, Facebook Lead This Week's IBD 50 Earnings

    IBD
  43. Apple, Facebook Lead Top IBD 50 Earnings This Week

    IBD
  44. IBD 50 Turns In Solid Week As Market Uptrend Resumes

    IBD
  45. The 5 Biggest Biotech Stocks

    Benzinga
  46. Jefferies 'Encouraged' By Biogen Idec's New Data

    Benzinga
  47. Nomura's Takeways From Biogen Idec's Analyst Meeting

    Benzinga
  48. Biogen Idec To Acquire Convergence Pharmaceuticals In Deal Worth ...

    Benzinga
  49. Meet 5 Top Medical Stocks Making Waves This Week

    IBD
  50. Stocks Turn Negative; Goodyear Triggers Sell Signal

    IBD
  51. A Look At 3 Biotech Stocks With Upside Potential

    Benzinga
  52. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  53. Stocks Reverse Lower On Good News/Bad News Job Data

    IBD
  54. Biogen drug results mixed

    IBD
  55. Nasdaq, S&P 500 Gap Up At Open, Hold Strong Gains

    IBD
  56. Biogen Nerve-Repair Drug Yields Mixed Results

    IBD
  57. Stock Market Surges; Nasdaq, S&P 500 Retake 50-Day Lines

    IBD
  58. Stocks Poised For Early Pop; Global Payments Gains

    IBD
  59. Stock Indexes Gun For Best Pop In 3 Weeks; Monster Breaks Out

    IBD
  60. Late-Session Rally Fades; Stocks End Firmly Lower

    IBD
  61. Oil's Drop Spooks Market Again, But REITs Outperform

    IBD
  62. Stocks Take It On The Chin Again; 10-Year Yield Plummets

    IBD
  63. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus
  64. What Investors Are Looking For In NPS Pharmaceuticals Ahead Of ...

    Benzinga
  65. Benzinga's Top Initiations

    Benzinga
  66. Barclays Initiates Biogen Idec At Overweight

    Benzinga
  67. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD
  68. Isis Pharma To Develop GI Drugs With J&J

    IBD
  69. An Investor's Guide: Market-Leading Industries In 2014

    IBD
  70. Stocks Reverse Lower; Apple Plunges Below Support

    IBD
  71. Stocks Surrender Early Gains, But Chip Stocks Outperform

    IBD
  72. 5 Biotech Stocks With Big News Due In January

    IBD
  73. Will 2015 Be Different For Big Cap Stocks?

    IBD
  74. Are There Any Winners Left In The Biotech Space?

    Benzinga
  75. How Gilead And Johnson & Johnson's Tumble Affected These Hedge ...

    Benzinga
  76. Fresh Milestones For Dow, S&P 500 But Biotechs Hit

    IBD
  77. Toys, Department Stores Rock, But Biotechs Tumble

    IBD
  78. Indexes Turn Mixed On Data; Celgene Dives

    IBD
  79. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  80. Broad Indexes Little Changed; Facebook Breaks Out

    IBD
  81. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  82. Morning Market Losers

    Benzinga
  83. Benzinga's Top #PreMarket Losers

    Benzinga
  84. Stocks Press Higher; Biotechs Gilead, Biogen Rise

    IBD
  85. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  86. Juiced By Fed, Stocks Rocket Higher; Biogen Up 6%

    IBD
  87. Stocks Hold Near Session Highs; FedEx Bounces Back

    IBD
  88. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD
  89. United Therapeutics: Will It Pass Peers In 2015?

    IBD
  90. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  91. The Biotech Stock With The Most Upside In 2015, According To ...

    Benzinga
  92. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus
  93. 3 Biotech ETFs Rally On Merger News

    Benzinga
  94. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD
  95. Will New Alzheimer's Drug Boost Biogen?

    IBD
  96. Stock Market Today: Stocks Worsen Near Midday; Airlines Rally

    IBD
  97. Biogen's Alzheimer's Drug Moves to Phase III

    GuruFocus
  98. Stock Market Today: Indexes Close Near Day's Highs

    IBD
  99. Great News For Biogen, But What's Next For The Stock?

    Benzinga
  100. Biogen Drug Test Advances

    IBD
Trading Center